Results 30,981-31,000 of 49,836 for speaker:Stephen Donnelly

Written Answers — Department of Health: Covid-19 Pandemic (12 Jul 2022)

Stephen Donnelly: Firstly I would like to extend my sincere gratitude to all healthcare workers for their efforts during this most challenging period. On January 19th, the Government announced a COVID-19 pandemic recognition payment for frontline public sector healthcare workers, to recognise their unique role during the pandemic. Following extensive engagement with healthcare unions on the matter, on 19th...

Written Answers — Department of Health: Care of the Elderly (12 Jul 2022)

Stephen Donnelly: I welcome the recently published report by University College Cork and Age Action on ‘Agency and Ageing in Place in Rural Ireland’. This important research report explores the experiences and preferences of older adults on ageing in place in rural Ireland and makes a number of recommendations to Government. Across Government, we will continue to prioritise the needs and...

Written Answers — Department of Health: Health Services (12 Jul 2022)

Stephen Donnelly: The Government recognises the important role that family carers play in the provision of care in Ireland. Family carers are the backbone of care provision in our country and have cared for the most vulnerable in our society during the COVID 19 pandemic. Whether caring for a child or a parent with a disability or illness or an elderly family member, carers, through their selfless hard work,...

Written Answers — Department of Health: Departmental Expenditure (12 Jul 2022)

Stephen Donnelly: Under Health Act 2004, the HSE reports its expenditure in line with the accounting standards specified by the Minister for Health. In practice, successive Ministers for Health have directed that the HSE should report its financial performance on an accruals basis, in accordance with Generally Accepted Accounting Principles (GAAP) applicable in the UK and Ireland, specifically Financial...

Written Answers — Department of Health: Hospital Staff (12 Jul 2022)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Hospital Services (12 Jul 2022)

Stephen Donnelly: The HSE Primary Care Eye Services Review Group (PCESRG) Report was launched in June 2017. The Report set out existing levels of service, models of service provision and the consultation process undertaken with patients, advocates, ophthalmic staff and representative bodies. It also highlighted the limitations of the existing model of service delivery, including the impact on waiting...

Written Answers — Department of Health: Hospital Appointments Status (12 Jul 2022)

Stephen Donnelly: As this refers to an individual case, I have referred this matter to the HSE for their attention and direct reply to the Deputy.

Written Answers — Department of Health: General Practitioner Services (12 Jul 2022)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Dental Services (12 Jul 2022)

Stephen Donnelly: Regarding the specifics referred to by the Deputy, I have asked my officials to contact the Deputy for more information, so that the matter can be referred to the HSE. Dental care services are provided to medical card holders aged 16 and over by private dental practitioners under contract to the HSE via the Dental Treatment Services Scheme (DTSS). I have been concerned for some time that...

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Stephen Donnelly: I propose to take Questions Nos. 974 and 975 together. Following a tender by the Office of Government Procurement, Mazars conducted a review of the governance structures around the HSE's drug reimbursement process. The report was submitted to my Department in January 2020. The review made recommendations in respect of the HSE’s systems, structures, processes, governance arrangements...

Written Answers — Department of Health: Health Strategies (12 Jul 2022)

Stephen Donnelly: I propose to take Questions Nos. 976, 977, 978, 979, 992 and 993 together. A disease or disorder is defined as rare in Europe when it affects less than 1 in 2000 people. There are approximately 8,000 known rare diseases; 80% of rare diseases are of genetic origin and are often chronic and life-threatening. Up to 1 person in 12 in Ireland may have a rare disease at some stage in their life....

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Stephen Donnelly: In response to the Bill, the Department of Health, HSE and National Centre for Pharmacoeconomics had significant, detailed engagement on the current processes. It was concluded that the current Act does not present legal barriers for the approval of orphan drugs for reimbursement. The 2013 Health Act does not include provision for a different ruleset when assessing orphan medicines....

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Stephen Donnelly: I propose to take Questions Nos. 981, 984, 986, 989 and 1099 together. The 2013 Health (Pricing and Supply of Medical Goods) Act is a clear, robust, statutory framework under which all new medicinal products must be assessed by the HSE. The HSE is the statutory decision-maker for the reimbursement of such products, and the Act ensures that these decisions are made on an objective and...

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Stephen Donnelly: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Stephen Donnelly: The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. HSE decisions on which medicines are reimbursed by the taxpayer are made on objective, scientific and economic grounds, on the advice of the National Centre for Pharmacoeconomics...

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Stephen Donnelly: I can confirm that interim and early access reimbursement models have been examined. The HSE and the Department would not support a pathway enabling reimbursement in the Irish context while further clinical evidence and data is collected on a given medicine. The HSE and NCPE advise that such a pathway would rest on the assumption that the collected data would support a positive...

Written Answers — Department of Health: Medicinal Products (12 Jul 2022)

Stephen Donnelly: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes. The 2013 Health (Pricing and Supply of Medical Goods) Act is a clear, robust, statutory framework under which all new medicinal products must be assessed by the HSE. The HSE is the statutory decision-maker for the reimbursement of such...

Written Answers — Department of Health: Healthcare Infrastructure Provision (12 Jul 2022)

Stephen Donnelly: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Written Answers — Department of Health: Healthcare Policy (12 Jul 2022)

Stephen Donnelly: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Dental Services (12 Jul 2022)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.